This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The 5 Dumbest Things on Wall Street: Jan. 20

4. Here's To You Metabolix

We here at the Five Dumbest Lab want to say one word to Metabolix (MBLX - Get Report) investors. Just one word. Are you listening?

Plastics. Yep, you got screwed by plastics.

Alright, technically it was bioplastics, but like Benjamin Braddock in The Graduate that lone word still won't provide much consolation or clarity to Metabolix stockholders who saw their worlds fall apart last Friday.

Shares of the company sank 57% after agri-giant Archer Daniels Midland (ADM - Get Report) backed out of their joint venture because of "uncertain" projected financial returns. The joint venture was created in 2006 to produce biodegradable plastics under the brand names Mirel and Mvera as alternatives to petroleum-based plastics.

ADM plans to keep the Iowa manufacturing plant after the divorce. Metabolix, which apparently never saw the break-up coming, says it will walk away with the intellectual property rights.

"Over the past few years, we have proven the technology at industrial scale and believe that we now have the opportunity to launch this business with a different business model," said Metabolix CEO Richard Eno in a statement.

Listen Richard, we know there are no winners when a marriage ends, but it's clear who the loser is in this case. While we appreciate the brave face, it's obviously time for you to take that $72 million of cash on your balance sheet and move on. You spent a solid 6 years trying to make it work with ADM, and you only booked $1.1 million in revenue in the past 12 months.

That's just sad. And as for relying on that $6 million Department of Energy grant you received last May, well, that's just not a sustainable business model even if you had viable supply source to replace ADM.

But you don't. So don't even try and seduce us into your stock.

Wait. You are trying to seduce us. Aren't you?
2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
NYX $0.00 0.00%
ADM $39.94 0.00%
CVX $102.18 0.00%
MBLX $1.52 0.00%
NVO $55.79 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs